Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Obagi Medical stock rises following 4Q results
Yahoo/AP
Saturday, March 16, 2013 - 10:41am
tags:
Obagi Medical Products, earnings
Ryan & Maniskas, LLP Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.
Yahoo/PR Newswire
Saturday, March 16, 2013 - 10:41am
tags:
Spectrum Pharmaceuticals, lawsuits
BioLineRx to Initiate HCV Study
Yahoo/Zacks
Saturday, March 16, 2013 - 10:40am
tags:
BioLineRx, HCV, BL-8020, hepatitis C
This Drug Needs a Wake-Up Call
Motley Fool
Saturday, March 16, 2013 - 10:39am
tags:
Bridion, anesthesia reversal
Pfizer's Read gets small raise in tough year
Fierce Pharma
Friday, March 15, 2013 - 11:46am
tags:
Ian Read, Pfizer, executive pay
Ex-J&J chief's 2012 pay outclasses Gorsky's by almost 3-to-1
Fierce Pharma
Friday, March 15, 2013 - 11:44am
tags:
JNJ, executive pay
Genomics Conference Illustrates That Illumina Is Outpacing The Competition
Seeking Alpha
Friday, March 15, 2013 - 11:43am
tags:
Illumina, genomics
Progenics Pharmaceuticals Earnings: Here’s Why the Stock is Rising Now
Wall St. Cheat Sheet
Friday, March 15, 2013 - 11:42am
tags:
earnings, Progenics
Anacor Pharmaceuticals Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, March 15, 2013 - 11:21am
tags:
earnings, Anacor
How Cambrex Corporation. Got More Awesome Last Quarter
Motley Fool
Friday, March 15, 2013 - 11:20am
tags:
Cambrex Corp
Titan Presents Compelling Opportunity Ahead Of PDAC Vote
Seeking Alpha
Friday, March 15, 2013 - 11:19am
tags:
Titan Pharmaceuticals, PDAC, Probuphine
Jury orders Illumina to pay $96M in patent lawsuit
Yahoo/AP
Friday, March 15, 2013 - 11:14am
tags:
patents, Illumina, Syntrix Biosystems
GlaxoSmithKline CEO says new drugs can be cheaper
Reuters
Friday, March 15, 2013 - 11:12am
tags:
Pharma CEOs, Andrew Witty, GSK, drug pricing
Vanda pulls EU filing for schizophrenia drug
Pharma Times, UK
Friday, March 15, 2013 - 11:11am
tags:
Europe, Vanda, schizophrenia, Fanaptum
FDA seeks to fast track Novartis lung cancer drug
Reuters
Friday, March 15, 2013 - 11:10am
tags:
FDA, fast track, Novartis, non-small cell lung cancer, LDK378
Teva Pays $2.3 Million For Pollution Violations
Pharmalot
Friday, March 15, 2013 - 11:08am
tags:
Teva, drug manufacturing, pollution
Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results
Yahoo
Friday, March 15, 2013 - 11:03am
tags:
earnings, Cardiome
Zogenix Earnings: Here’s Why the Stock is Rising Now
Wall St. Cheat Sheet
Friday, March 15, 2013 - 11:02am
tags:
Zogenix, earnings
Merck anesthesia-reversal agent faces new delay
Reuters
Friday, March 15, 2013 - 11:01am
tags:
Merck, anesthesia reversal, sugammadex
Agilent And The Boom In Companion Diagnostics
Seeking Alpha
Friday, March 15, 2013 - 10:59am
tags:
Agilent, companion diagnostics, Amgen, Eli Lilly, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.